Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 2, 2021PLoS PathogensOpen Access

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination

View Full Paper
Ask AI
Bookmark
Share

Authors

CDChristopher DavisNLNicola LoganGTGrace Tyson

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Davis et al. (2021) studied this question.

synapsesocial.com/papers/6a97b03e761fafb16923a2dahttps://doi.org/10.1371/journal.ppat.1010022
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma2021 · 712 citations
  2. 2Why is India having a covid-19 surge?2021 · 114 citations
  3. 3SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern2021 · 465 citations
  4. 4SARS-CoV-2 variants: levels of neutralisation required for protective immunity2021 · 26 citations
  5. 5Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting2020 · 24 citations